|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 9/22 | |||
| A61K 31/195 | |||
| A61K 31/216 | |||
| A61K 45/06 | |||
| A61P 25/16 | |||
| A61K 9/24 |
| (11) | Number of the document | 2515876 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10778748.3 |
| Date of filing the European patent application | 2010-11-08 | |
| (97) | Date of publication of the European application | 2012-10-31 |
| (45) | Date of publication and mention of the grant of the patent | 2016-01-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/002937 |
| Date | 2010-11-08 |
| (87) | Number | WO 2011/056240 |
| Date | 2011-05-12 |
| (30) | Number | Date | Country code |
| 259567 P | 2009-11-09 | US |
| (72) |
MAO, Chen, US
PARGAONKAR, Nikhil, US
MAURER, Laura E., US
MA, Sarina Grace Harris, US
|
| (73) |
XenoPort, Inc.,
3410 Central Expressway, Santa Clara, CA 95051,
US
|
| (54) | PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF A LEVODOPA PRODRUG AND METHODS OF USE |
| PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF A LEVODOPA PRODRUG AND METHODS OF USE |